Advertisement

Investor, Andy Smith, reviews some of the lessons from cancer clinical trials and examples of what investors have learned from compounds in development and a paradox in oncology clinical trials. Companies mentioned in this talk include AstraZeneca, OSI Pharma and Antisoma.

You need to upgrade your Flash Player!

This web site makes use of the Macromedia Flash player 8.

VIDEO PLAYER by 3b nexus
Advertisement
Advertisement